These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7551410)

  • 41. Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study.
    Pizzichini MM; Pizzichini E; Efthimiadis A; Chauhan AJ; Johnston SL; Hussack P; Mahony J; Dolovich J; Hargreave FE
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1178-84. PubMed ID: 9769279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of a low concentration of hypochlorous acid on rhinovirus infection of nasal epithelial cells.
    Yu MS; Park HW; Kwon HJ; Jang YJ
    Am J Rhinol Allergy; 2011; 25(1):40-4. PubMed ID: 21711976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Establishment of a mouse model for human rhinovirus infection.
    Yin FH; Lomax NB
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2335-40. PubMed ID: 3023527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of illness from rhinovirus infection by a topical interferon inducer.
    Panusarn C; Stanley ED; Dirda V; Rubenis M; Jackson GG
    N Engl J Med; 1974 Jul; 291(2):57-61. PubMed ID: 4365144
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of experimental rhinovirus 16 infection on airway hyperresponsiveness to bradykinin in asthmatic subjects in vivo.
    Grünberg K; Kuijpers EA; de Klerk EP; de Gouw HW; Kroes AC; Dick EC; Sterk PJ
    Am J Respir Crit Care Med; 1997 Mar; 155(3):833-8. PubMed ID: 9117013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human airway submucosal glands augment eosinophil chemotaxis during rhinovirus infection.
    Furukawa E; Ohrui T; Yamaya M; Suzuki T; Nakasato H; Sasaki T; Kanda A; Yasuda H; Nishimura H; Sasaki H
    Clin Exp Allergy; 2004 May; 34(5):704-11. PubMed ID: 15144460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rhinovirus regulation of IL-1 receptor antagonist in vivo and in vitro: a potential mechanism of symptom resolution.
    Yoon HJ; Zhu Z; Gwaltney JM; Elias JA
    J Immunol; 1999 Jun; 162(12):7461-9. PubMed ID: 10358201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical effects of rhinovirus infections.
    Peltola V; Waris M; Osterback R; Susi P; Hyypiä T; Ruuskanen O
    J Clin Virol; 2008 Dec; 43(4):411-4. PubMed ID: 18835215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rhinoviruses infect the lower airways.
    Papadopoulos NG; Bates PJ; Bardin PG; Papi A; Leir SH; Fraenkel DJ; Meyer J; Lackie PM; Sanderson G; Holgate ST; Johnston SL
    J Infect Dis; 2000 Jun; 181(6):1875-84. PubMed ID: 10837165
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of nasal nitric oxide in the resolution of experimental rhinovirus infection.
    Sanders SP; Proud D; Permutt S; Siekierski ES; Yachechko R; Liu MC
    J Allergy Clin Immunol; 2004 Apr; 113(4):697-702. PubMed ID: 15100676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rhinovirus enters but does not replicate inside monocytes and airway macrophages.
    Gern JE; Dick EC; Lee WM; Murray S; Meyer K; Handzel ZT; Busse WW
    J Immunol; 1996 Jan; 156(2):621-7. PubMed ID: 8543813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fireside conference 11. Common cold.
    Winther B; Kawana R; Saito H
    Rhinol Suppl; 1992; 14():228-32. PubMed ID: 1327017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resistance of differentiated human airway epithelium to infection by rhinovirus.
    Lopez-Souza N; Dolganov G; Dubin R; Sachs LA; Sassina L; Sporer H; Yagi S; Schnurr D; Boushey HA; Widdicombe JH
    Am J Physiol Lung Cell Mol Physiol; 2004 Feb; 286(2):L373-81. PubMed ID: 14711802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical and biological impact of viral respiratory infections on the human airway: focus on the rhinovirus.
    Spiteri MA; Bianco A
    Monaldi Arch Chest Dis; 1998 Feb; 53(1):80-2. PubMed ID: 9632913
    [No Abstract]   [Full Text] [Related]  

  • 55. [Suppression of rhinovirus infections with macrolide antibiotics].
    Yamatani M; Suzuki T; Sasaki A; Yasuda H; Inoue D; Sasaki H
    Jpn J Antibiot; 2003 Apr; 56 Suppl A():72-7. PubMed ID: 14679752
    [No Abstract]   [Full Text] [Related]  

  • 56. Short-term repeated HRV-16 exposure results in an attenuated immune response in vivo in humans.
    Koch RM; Kox M; van den Kieboom C; Ferwerda G; Gerretsen J; Ten Bruggencate S; van der Hoeven JG; de Jonge MI; Pickkers P
    PLoS One; 2018; 13(2):e0191937. PubMed ID: 29447199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prechallenge antibodies: moderators of infection rate, signs, and symptoms in adults experimentally challenged with rhinovirus type 39.
    Alper CM; Doyle WJ; Skoner DP; Buchman CA; Seroky JT; Gwaltney JM; Cohen SA
    Laryngoscope; 1996 Oct; 106(10):1298-305. PubMed ID: 8849805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ciliated nasal epithelial cells damage and human rhinovirus infection: cytological findings.
    Martinez-Giron R; Van Woerden HC; Martínez-Torre C
    Acta Biomed; 2020 Mar; 91(1):146-147. PubMed ID: 32191672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The host response, not the virus, causes the symptoms of the common cold.
    Hendley JO
    Clin Infect Dis; 1998 Apr; 26(4):847-8. PubMed ID: 9564460
    [No Abstract]   [Full Text] [Related]  

  • 60. The rhinovirus--not such an innocent?
    Papadopoulos N; Johnston S
    QJM; 2001 Jan; 94(1):1-3. PubMed ID: 11161129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.